Intravenous iron therapy for patients with heart failure: expanding body of evidence

Intravenous iron therapy for patients with heart failure: expanding body of evidence

Bibliographic Details
Main Author:	Christopher Adlbrecht
Format:	Article
Language:	English
Published:	Wiley 2019-08-01
Series:	ESC Heart Failure
Online Access:	https://doi.org/10.1002/ehf2.12490

Similar Items

Intravenous iron in heart failure and chronic kidney disease
by: Patricia Carrilho
Published: (2021-07-01)

Heart failure in patients with kidney disease and iron deficiency: The role of iron therapy
by: Aleix Cases Amenós, et al.
Published: (2017-11-01)

Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores
by: Aleksandra Paterek, et al.
Published: (2018-10-01)

Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
by: Todd A. Koch, et al.
Published: (2015-01-01)

Intravenous Iron Sucrose Therapy in Iron Deficiency Anemia in Antenatal and Postnatal Patients
by: Jyotshna Sharma, et al.
Published: (2015-06-01)

Intravenous Iron Sucrose Therapy in Iron Deficiency Anemia in Antenatal and Postnatal Patients
by: Jyotshna Sharma, et al.
Published: (2015-06-01)

Current practice and effects of intravenous anticoagulant therapy in hospitalized acute heart failure patients with sinus rhythm
by: Hiroki Nakano, et al.
Published: (2021-01-01)

Iron replacement therapy in heart failure: a literature review
by: Hassan Ismahel, et al.
Published: (2021-09-01)

Prevalence of iron deficiency in patients with heart failure
by: Dersim Muslih Hussein
Published: (2018-01-01)

The effect of intravenous iron therapy on total antioxidant capacity in patients with iron deficiency anemia
by: Mehmet Sinan Dal, et al.
Published: (2011-09-01)

Clinical effects of adding tolvaptan to intravenous furosemide in patients with congestive heart failure
by: Mahoto Kato, et al.
Published: (2017-01-01)

Iron deficiency in heart failure
by: Goran Loncar, et al.
Published: (2021-08-01)

Iron deficiency and heart failure
by: Mesut Rushid, et al.
Published: (2020-07-01)

The effect of intravenous Iron therapy on haemoglobin level and optimization of erythropoietin therapy in haemodialysis patients
by: M.Mojerlu (MD), et al.
Published: (2006-04-01)

Role of iron carboxymaltose therapy in heart failure with reduced ejection fraction
by: V.K. Katyal, et al.
Published: (2017-11-01)

Chagas Disease and Heart Failure: An Expanding Issue Worldwide
by: Felipe Martinez, et al.
Published: (2019-07-01)

IRON DEFICIENCY AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. I. Stuklov
Published: (2017-11-01)

Long-Term Efficacy of Postpartum Intravenous Iron Therapy
by: Nadine Becuzzi, et al.
Published: (2014-01-01)

On the relevance of outpatient intravenous iron therapy for anemia management
by: Manuel Muñoz
Published: (2011-12-01)

Long‐term administration of intravenous inotropes in advanced heart failure
by: Piero Gentile, et al.
Published: (2021-10-01)

Iron deficiency and iron deficiency anaemia in elderly patients with chronic heart failure
by: Lorenzo Palleschi, et al.
Published: (2017-12-01)

Maintenance Intravenous Iron Therapy in Hepmodialysis Patients Receiving Recombinant Human Erythropoientin
by: Romeh Saleh, et al.
Published: (1999-01-01)

Ultra‐high dose intravenous nitroglycerin in an ESRD patient with acutely decompensated heart failure
by: Michael Gyory, et al.
Published: (2021-04-01)

Oral versus intravenous iron therapy in iron deficiency anemia: An observational study
by: Samarendra N Das, et al.
Published: (2020-01-01)

RESYNCHRONIZATION THERAPY IN PATIENTS WITH HEART FAILURE
by: Tomislav Kostić, et al.
Published: (2013-06-01)

Anemia and iron deficiency in heart failure
by: Victor M. Gil, et al.
Published: (2014-01-01)

Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis
by: Stein J, et al.
Published: (2018-02-01)

Iron Deficiency: A New Target for Patients With Heart Failure
by: Caterina Rizzo, et al.
Published: (2021-08-01)

The Influence of Cardiovascular Medications on Iron Metabolism in Patients with Heart Failure
by: Oana Sirbu, et al.
Published: (2019-07-01)

The Management of Co-Morbidities in Patients with Heart Failure – Iron Deficiency
by: Stephan von Haehling, et al.
Published: (2017-01-01)

Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery
by: Cinzia Nugara, et al.
Published: (2020-03-01)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
by: Fozia Z. Ahmed, et al.
Published: (2021-10-01)

Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy
by: Alka Kriplani, et al.
Published: (2013-01-01)

Intravenous iron therapy: how far have we come?
by: Rodolfo Delfini Cançado, et al.
Published: (2011-12-01)

Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients
by: Antoine Jobbé-Duval, et al.
Published: (2021-06-01)

Options for intravenous iron supplementation in hemodialysis patients
by: Ji Yoon Kong, et al.
Published: (2020-09-01)

The Benefits of Yoga Therapy for Heart Failure Patients
by: Pullen, Paula Rei
Published: (2009)

Iron Deficiency in Acute Decompensated Heart Failure
by: Anna Beale, et al.
Published: (2019-10-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

Cannot write session to /tmp/vufind_sessions/sess_la4nros75kqsud0c6ttvert6m8